All In Biotech

Free tool

FAERS Monitor: Palonosetron Hydrochloride

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 207963 or its brand name (Palonosetron Hydrochloride, Palonosetron Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

1,801

Serious

1,727

96% of reports

Hospitalization

984

Death reported

354

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea169
  • neutrophil count decreased151
  • off label use144
  • anaemia118
  • pyrexia113
  • white blood cell count decreased112
  • diarrhoea108
  • platelet count decreased108
  • vomiting100
  • decreased appetite95
  • myelosuppression93
  • death88
  • febrile neutropenia85
  • pneumonia85
  • fatigue82

Reports by year received

View as table
YearReports
20045
20058
20067
20074
20098
201014
201116
201258
201333
201441
201552
2016103
201763
2018105
201972
2020108
2021194
2022218
2023237
2024159
2025196
2026100

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,358 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
neutrophil count decreasedSignal15143.437.36,205
myelosuppressionSignal9330.224.82,597
febrile neutropeniaSignal8515.012.21,097
white blood cell count decreasedSignal11212.110.11,132
platelet count decreasedSignal10811.89.91,066
anaemiaSignal1187.26.1633
decreased appetiteSignal954.83.9283
pyrexiaSignal1133.83.2236
pneumoniaSignal853.12.5118
nauseaSignal1692.52.2156
vomitingSignal1002.52.189
diarrhoea1082.01.651
off label use1441.91.665
fatigue821.21.03
death881.21.03

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.